- Article metrics
- Last updated: Tue, 7 May 2024 14:03:18 Z
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
Access & Citations
-
- 2304
- Article Accesses
-
- 0
- Web of Science
-
- 1
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.